Stroke/Cerebrovascular Disease Perspective

  • 15 Studies That Challenged Medical Dogma in 2018 Dr Eric Topol highlights articles that turned prevailing wisdom on its head over the past year.
  • The Year in Neurology 2018   New studies in 2018: Dr Hans-Christoph Diener discusses recent results from studies across neurology that have led to practice changes.
  • The Top Cardiology Trials of 2018 in Review Contrasting studies on the benefits of percutaneous mitral valve repair and a fall from grace for aspirin make the list for Bob Harrington and Mike Gibson. Find out what else piqued their interest.
  • Dual vs Triple Antithrombotic Therapy? The Debate Continues   Is a NOAC plus an antiplatelet drug enough to prevent thromboses? Stroke? What doses and combinations are safest? Christian Ruff, Mike Gibson, and Chris Cannon examine the evidence.
  • Mandrola's Top 10 Cardiology Stories of 2018 From blood pressure management in the community to a study on potentially biased referees -- John Mandrola reviews his picks for the year's big stories in cardiology and medicine.
  • What It Takes to Be a Top 10 Stroke Hospital Dr Andrew Wilner on how physician surveys of top hospitals provide models of success worth emulating.
  • How to Know When It's Autoimmune Epilepsy A conversation between Drs Andrew Wilner and Batool Kirmani on the red flags your patient may have this difficult-to-diagnosis condition.
  • Beyond Statins: PCSK9 Inhibitors, Ezetimibe, and Diet   Experts from the Mayo Clinic discuss the spectrum of nonstatin therapies and when they consider using ezetimibe and PCSK9 inhibitors in their patients at high cardiovascular risk.
  • ACC/AHA 2018 Cholesterol Guideline: The New and the Old   Drs Michael Blaha and Salim Virani review key takeaways from the 2018 ACC/AHA updated cholesterol guideline, noting that much is new in management of patients with elevated lipids.
  • VITAL Results for Vitamin D and Omega-3s   The largest prospective randomized trial of vitamin D and omega-3 supplementation provides much-needed information.
  • CV Risk: Can Prescription Omega-3 REDUCE-IT?   Low-dose omega-3 flopped for CV risk reduction. Melissa Walton-Shirley, MD, dissects the REDUCE-IT trial from AHA, which used high-dose prescription EPA, with principal investigator, Deepak Bhatt, MD.
  • AHA 2018Lipid Lollapalooza at AHA 2018 The release of the 2018 cholesterol guidelines and a bunch of lipid-oriented trials made it a bountiful day at the American Heart Association meeting for Melissa Walton-Shirley, MD.
  • AHA 2018Pure Fish Oil Lowers CVD Risk Even If We Don’t Understand How REDUCE-IT found that high-dose purified omega-3 fish oil reduced CV events even if the drug didn’t work as expected. Evidence-based practice means we should embrace these results, says John Mandrola, MD.
  • Mediterranean Diet's Benefits May Extend to Multiple Diseases Dr William F. Balistreri on the latest evidence showing how we can eat our way toward improved health.
  • Mandrola Previews AHA 2018 Among the highlights for the upcoming American Heart Association Scientific Sessions are studies on omega-3, inflammation, a potential EP breakthrough, and yoga. Not to mention new lipid guidelines.
  • Prevention of Type 2 Diabetes Highlighted at EASD 2018 Dietary changes and regular exercise are proven interventions that reduce the risk for type 2 diabetes, but with rates of obesity on the rise, other strategies may be required.
  • Could It Be the Sugar?   A 'battle royale' is brewing in the nutrition science field.
  • Death Certificates: Do We Always Know 'Cause of Death'? Getting cause of death right is important. But is it achievable?
  • Can Tight Blood Pressure Control Prevent Dementia?   Dr Richard Isaacson discusses recent results from the SPRINT MIND study exploring the link between blood pressure and dementia risk.
  • Don't Tell Patients to Ditch the Low-Fat Dairy Just Yet   PURE data suggest that whole-fat dairy intake lowers mortality, but official recommendations haven't changed.
look on

our company